|
Deutsche Krebsgesellschaft e.V. , Frankfurt am Main http://www.krebsgesellschaft.de/krebshaeufigkeit,11267.html |
Grant WB, Holick MF. Benefits and requirements of vitamin D for optimal health: a review. Altern Med Rev 2005;10(2):94-111. |
van den Bemd GJ, Chang GT. Vitamin D and vitamin D analogs in cancer treatment. Curr Drug Targets 2002;3(1):85-94. |
Garland CF et al. The role of vitamin D in cancer prevention. Am J Public Health 2006;96(2):252-261. |
Gorham ED, Garland CF, Garland FC et al. Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol 2005;97(1-2):179-194. |
Giovannucci E. The epidemiology of vitamin D and colorectal cancer: recent findings. Curr Opin Gastroenterol 2006;22(1):24-29. |
Hartman TJ et al. The association of calcium and vitamin D with risk of colorectal adenomas. J Nutr 2005;135:252-259. |
John EM, Schwartz GG, Koo J, Van Den BD, Ingles SA. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res
2005;65:5470-5479. |
Woo TC, Choo R, Jamieson M, Chander S, Vieth R. Pilot study: potential role of vitamin D (cholecalciferol) in patients with PSA relapse after definitive therapy. Nutr Cancer
2005;51(1):32-36. |
van Veldhuizen PJ et al. Treatment of vitamin D deficiency in patients with metastatic prostate cancer may improve bone pain and muscle strength. J Urol
2000;163(1):187-190. |
Bertone-Johnson ER et al. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14:1991-1997. |
BŽrubŽ S et al. Vitamin D, calcium, and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 2004;13(9):1466-1472. |
Zhou W, Suk R, Liu G et al. Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev
2005;14,10:2303-2309. |
Nakagawa K et al. 1 alpha,25-Dihydroxyvitamin D 3 is a preventive factor in the metastasis of lung cancer. Carcinogenesis 2005;26(2):429-440. |
Ringe JD, Burckhardt P (Hrsg). Vitamin D, Kalzium in der Osteoporosetherapie. Stuttgart: Gustav Thieme Verlag 1999. |
Vieth R, Ladak Y, Walfish PG. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults
require more vitamin D. J Clin Endocrinol Metab. 2003; 88(1): 185-191. |
Bothe V, Schmidt-Gayk H. Competitive protein binding assay for the diagnosis of hyper- and hypovitaminosis D. In: Schmidt-Gayk H, Armbruster FP, Bouillon R (Hrsg).
Calcium regulating hormones, vitamin D metabolites, and cyclic AMP. Assays and their clinical application. Heidelberg: Springer 1990; 258-279. |
Peacock M. Osteomalacia and rickets. In: Nordin BEC, Need AG, Morris HA (Hrsg). Metabolic bone and stone disease. Edinburgh: Churchill Livingstone 1993; 83-108.
|